Obesity-associated hyperactivation of the insulin/Insulin-like Growth Factor 1 (IGF-1) signaling pathway further facilitates tumor cell energy metabolic reprogramming and protein synthesis through the mTORC1 pathway, thereby providing the bioenergetic foundation for liver metastasis (125). Here, IGF1 is linked to obesity disorder.